baber/WOPTO huggingface dataset:
Patent AU-2018367704-A1 (AU)
Title: Method and apparatus for transmitting and receiving control information in wireless communication system
Inventor: PARK SUNG JIN
IPC: H04W72/12
Filed: 2018-11-06
Abstract: The present disclosure relates to a method and an apparatus for receiving control information in a wireless communication system. A method for receiving control information according to some embodiments may comprise the steps of: receiving scheduling configuration information; receiving slot format information; determining a slot format of at least one slot on the basis of the scheduling configuration information and the slot format information; and receiving at least one from among first type control information and second type control information on the basis of a result of the determination.
Patent AU-2018388482-A1 (AU)
Title: Pyrazole N-linked carbamoyl cyclohexyl acids as LPA antagonists
Inventor: SHI YAN
IPC: A61P11/06
Filed: 2018-12-18
Abstract: The present invention provides compounds of Formula (I) or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein X
Patent AU-2018388483-A1 (AU)
Title: Interference mitigation based on antenna system phase distribution
Inventor: HAYES GERARD JAMES
IPC: H04B7/185
Filed: 2018-12-18
Abstract: A method of interference mitigation may include receiving a desired signal from an asset of the system at an antenna assembly and associating the desired signal with relative phase distribution information based on a relative location of origin of the desired signal where the relative phase distribution information is predetermined for the antenna assembly. The method further includes receiving an interfering signal and associating the interfering signal with relative phase distribution information based on a relative location of origin of the interfering signal where the desired signal and the interfering signal forming a received signal set. The method further includes normalizing signals of the received signal set to respective relative phases associated with each respective relative location of origin, and performing interference cancellation of the interfering signal based on the normalized signals.
Patent AU-2018409334-A1 (AU)
Title: Control apparatus for power supply system, control method for power supply system, and power supply system
Inventor: MONDEN YUKITAKA
IPC: H01M8/0656
Filed: 2018-02-19
Abstract: The present invention provides a control apparatus for a power supply system. A power supply system according to this embodiment is provided with: a hydrogen power generation device which generates hydrogen by using electric power supplied from a power generation device using renewable energy, and supplies the electric power generated by the generated hydrogen to a load; and a battery which has a faster control response than the hydrogen power generation device and charges/discharges an excessive/insufficient amount of the electric power supplied from the power generation device to the load. This control apparatus for a power supply system is provided with: an acquisition unit which acquires information on the remaining amount of energy in the battery; and a control unit which, on the basis of the information, performs a control to cause the hydrogen generation device to start generating power when it is predicted that the remaining amount of energy in the battery will reach a first threshold value in a predetermined time.
Patent AU-2018449220-A1 (AU)
Title: Electrosurgical system
Inventor: SIAZON KEVIN
IPC: A61B18/12
Filed: 2018-11-16
Abstract: An electrosurgical system is provided and includes a bipolar electrosurgical instrument and an electrosurgical generator. The bipolar electrosurgical instrument is arranged to seal and cut tissue captured between jaws of the instrument. The jaws include particularly positioned, shaped and/or oriented electrodes to perform the sealing of tissue. The electrosurgical generator is arranged to supply RF energy through the instrument, monitor the supplied RF energy and adjust or terminate the supplied RF energy to optimally seal the tissue.
Patent WO-2019232589-A1 (WO)
Title: Biodegradable implant with tuneable characteristics for orthopedic applications
Inventor: DEHGHANI FARIBA
IPC: C08L69/00
Filed: 2019-06-07
Abstract: Biodegradable polymers are appealing materials for the manufacture of surgical implants that are required to break down in vivo, negating the need for a subsequent removal operation. Many biocompatible polymers produce acidic breakdown products that can lead to localised inflammation and osteolysis. The present invention relates to implants fabricated from a poly(propylene carbonate) and starch blend (PPC-starch) that degrades into carbon dioxide and water. The basic compressive modulus of PPC-starch (1:1 w/w) is 34 MPa, however the addition of glycerol (1% w/w) and water as plasticisers doubles this value and enhances the surface wettability. The bioactivity and stiffness of PPC-starch blends is increased by the addition of bioglass microparticles (10% w/w) as shown by in vitro osteoblast differentiation assay and mechanical testing. MicroCT analysis confirms that the bioglass microparticles are evenly distributed throughout biomaterial. PPC-starch-bioglass was tested in vivo in two animal models. A murine subcutaneous pellet degradation assay demonstrates that the volume fraction loss for the PPC-starch-bioglass blend is 46% after 6 months post-surgery, whilst it is 27% for poly(lactic acid). In a rat knee implantation model, PPC-starch-bioglass screws inserted into the distal femur show osseointegration with no localised adverse effects after 3 and 12 weeks. These data support the further development PPC-starch-bioglass as a medical biomaterial.
Patent AU-2019201097-A1 (AU)
Title: Fastener pusher with an improved workpiece-contact element
Inventor: RYAN PATRICK
IPC: B25C1/08
Filed: 2019-02-15
Abstract: Abstract Various embodiments of the present disclosure provide a workpiece contact element for a fastener pusher. In one embodiment, the workpiece contact element includes an attachment side, a workpiece-contact surface, and one or more fastener-exit surfaces defining a fastener-exit throughbore having a longitudinal axis and extending through the workpiece-contact surface. The workpiece-contact surface forms an annular protrusion extending away from the attachment side.
Patent AU-2019201877-A1 (AU)
Title: Electronic torque wrench
Inventor: GAUTHIER MICHAEL T
IPC: A61B17/88
Filed: 2019-03-18
Abstract: The present invention relates to tools, and more specifically to tools including electronic measuring and display device for providing indication of the forces being applied by the tools. According to one aspect of the present invention, an electronic torque wrench is provided for engaging a workpiece in a sterile environment, the electronic torque wrench including a wrench body with a wrench head disposed on the wrench body, wherein the wrench head is configured to engage the workpiece. A grip handle is disposed on the wrench body opposite the wrench head and a user interface is carried by the wrench body which is also connected to a microprocessor disposed within the handle or optionally at a location spaced from the handle. In one embodiment, the user interface includes a display with a first readout and a second readout, and an input device for inputting a preset torque value, all of which are operably connected to the microprocessor. The first readout displays a peak torque value continuously during operations and the second readout displays an applied torque value continuously during operations. WO2014/082087 PCT/US2013/072058 2042 201 F2010
Patent AU-2019202616-A1 (AU)
Title: Control system and method for vehicles with dynamic braking
Inventor: PETRAK EDWARD THOMAS
IPC: H02P3/20
Filed: 2019-04-16
Abstract: A control system includes a current sensor and one or more processors. The current sensor is configured to be disposed onboard a vehicle and to monitor a measured current conducted into a resistor leg of the vehicle. The resistor leg has a braking chopper and one or more resistive elements, and is connected with a traction bus of the vehicle. The one or more processors are configured to receive the measured current from the current sensor and, in response to the measured current differing from an expected current through the resistor leg, the one or more processors are configured to generate a control signal configured to one or more of increase an engine speed of an engine of the vehicle, increase cooling to the one or more resistive elements of the resistor leg, restrict movement of the vehicle, or schedule maintenance for the resistor leg. 400-> 3/3 Calculate expected current through resistor leg connected to traction bus of vehicle 402 Compare expected current to measured current through resistor leg monitored by sensor 404 NO0 Difference between expected YES current and measured current exceed designated threshold? Determine resistor leg Identify abnormal properly functioning 408/ resistor leg Generate control signal 409 to decrease engine 411 speed or maintain Increase 414 current engine speed engine speed Increase Cooling Schedule maintenance Impose movementImanenc 410 restriction on vehicle Generate alert to notify 412 operator
Patent AU-2019204451-A1 (AU)
Title: Oral treatment device
Inventor: DEMAREST SCOTT
IPC: A61C19/06
Filed: 2019-06-25
Abstract: Abstract An oral treatment device that emits light onto surfaces of a user's teeth. In one aspect, the oral treatment device includes an intraoral mouthpiece. The mouthpiece comprises a lamp support structure comprising a lamp support surface and is formed of a first material. A flexible lamp is mounted to the lamp support surface so that a light emitting surface of the flexible lamp assumes a concave curvature, thereby forming a lamp assembly. A guard component is overmolded to the lamp assembly. The guard component is formed of an elastomeric material having a hardness that is less than a hardness of the first material. In one embodiment, the oral treatment device may be a teeth whitening device. WO 2017/112597 PCT/US2016/067573 105 107 108
Patent AU-2019204859-A1 (AU)
Title: Inter Partes Wall Module
Inventor: BAXTER RYAN
IPC: E04B1/343
Filed: 2019-07-05
Abstract: Abstract 5 A self-contained prefabricated wall module for installation as a single assembly for forming an inter partes wall between two adjacent apartments or residential units of a multi-dwelling building structure includes a light weight intermediate core wall, typically made from 10 interlocking autoclaved aerated concrete panels located intermediate a first outer support wall or load bearing stud wall structure of metal or timber studs and suitable covering or lining, typically fire resistant plasterboard or dry wall board on one side, and another outer support 15 wall or load bearing stud wall structure of metal or timber studs and suitable covering or lining on the other side wherein the cavities of the stud walls are provided with insulation, typically in the form of batts, provides improved separation and isolation between the adjacent 20 units. The advantage of the prefabricated wall module is that the various multiple components are able to be assembled together to form a single assembly in a factory for transportation by road as an integral unit for lifting into place within a building structure at a building site 25 to form a dividing wall thereby saving time and effort by requiring less experienced and skilled work operatives to build the dividing wall. 11504050_1 (GHMatters) P108896.AU.1 5/07/19 I"C" 72b"B" 72a -74 50 70a0 3b50 3 5 d 4bFIGURE 5b
Patent AU-2019208236-A1 (AU)
Title: Data platform and analytics for predicting media metrics
Inventor: POYNTER NICOLA SARAH VANESSA
IPC: G06Q30/02
Filed: 2019-07-25
Abstract: A device obtains data, for a current media plan, that includes a cost adjustment factor, a duration of an unexecuted portion of the current media plan that is divisible into periods of time, and an unutilized budget, for the duration, that is divisible into budget portions based on the periods of time. The device generates a predictive baseline cost parameter by adjusting, by the cost adjustment factor, a baseline cost parameter of a previously implemented baseline media plan. The device predicts cost metrics for the current media plan using the predictive baseline cost parameter, and predicts performance metrics for the current media plan based on the cost metrics and predictive baseline cost parameter. The device determines target cost per point (CPP) values for the current media plan based on the cost metrics and performance metrics, and causes an action to be performed based on the target CPP values.
Patent AU-2019216420-A1 (AU)
Title: Chimeric antigen receptors targeting CD70
Inventor: SRIVATSA SRINIVASAN SURABHI
IPC: A61K39/00
Filed: 2019-01-31
Abstract: The disclosure provides CARs (CARs) that specifically bind to CD70. The disclosure further relates to engineered immune cells comprising such CARs, CAR-encoding nucleic acids, and methods of making such CARs, engineered immune cells, and nucleic acids. The disclosure further relates to therapeutic methods for use of these CARs and engineered immune cells comprising these CARs for the treatment of a condition associated with malignant cells expressing CD70 (e.g., cancer).
Patent AU-2019216634-A1 (AU)
Title: Omega-3 pentaenoic acid compositions and methods of use
Inventor: BOBOTAS GEORGE
IPC: C12P7/64
Filed: 2019-08-14
Abstract: Il:\szp\nterwov \NRPortbI\DCC\SZP\15727135_ Ldocx-22/09/207 Orally administrable composition comprising fatty acids, wherein at least 50% by weight of the fatty acids comprise omega-3-fatty acids, salts or derivatives thereof, wherein the omega-3 fatty acids comprise eicosapentaenoic acid (EPA; C20:5-n3), docosapentaenoic acid (DPA; C22:5-n3), and docosahexaenoic acid (DHA; C22:6 n3), wherein the ratio of DHA to EPA (DHA:EPA) is less than 1:20, and wherein the ratio of DHA to DPA (DHA:DPA) is less than 2:1 are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, CNS, inflammatory, and other diseases/conditions or risk factors therefore.
Patent AU-2019226219-A1 (AU)
Title: Genetic factors associated with inhibitor development in hemophilia a
Inventor: BERNTORP ERIK
IPC: C12Q1/68
Filed: 2019-09-06
Abstract: The present invention provides methods for predicting the risk of an individual developing antibodies to factor Vill by identifying a single nucleotide polymorphism of an immune response or immune modifier gene. The invention further provides oligonucleotides, diagnostic kits, microarrays, and isolated nucleic acids comprising single nucleotide polymorphisms of immune response or immune modifier genes.
Patent AU-2019232893-A1 (AU)
Title: Manufacturing method of rails for heavy-haul railways
Inventor: YUAN JUN
IPC: C21D9/04
Filed: 2019-09-20
Abstract: Abstract The invention relates to the field of rail preparation method, in particular to a manufacturing method of rails for heavy-haul railways, which can reduce the austenite grain size, refine the interlaminar spacing of pearlite, improve the rail strength and continuously improve the toughness of rails. It comprises the steps of: allowing a rail to be subjected to the primary heat treatment by using waste heat of rolling, heating the rail to 650 °C - 700 °C by a heating device, returning the rail to a heat treatment unit for secondary heat treatment, and quickly withdrawing the rail from the heat treatment unit. In this invention, since the interlaminar spacing has been refined through the primary heat treatment, the interlaminar spacing of pearlite can be further refined after the secondary heat treatment to improve the strength and toughness of rails. The rails produced by the method can reach the tensile strength of more than 1380MPa, and the fracture toughness of not less than 38MPa-mi/2 at -20 °C, thus providing the excellent wear resistance and contact fatigue resistance. The invention is especially suitable for the production of rails for heavy-haul railways.
Patent AU-2019250230-A1 (AU)
Title: Compositions and methods for topical delivery of prostaglandins to subcutaneous fat
Inventor: SINGER MICHAEL S
IPC: A61K31/5575
Filed: 2019-10-18
Abstract: Described herein are compositions comprising a prostaglandin FP receptor agonist (PFPRA) compound and a fatty acid ester (e.g., isopropyl myristate), optionally comprising an ointment base such as a hydrocarbon base (e.g., petroleum jelly) and/or an organic alcohol (e.g., propylene glycol), that, when topically applied to the skin, locally delivers a therapeutically effective amount of the PFPRA compound to subcutaneous fat under the skin, and methods of preparation. The therapeutic effect is, for example, reduction of the subcutaneous fat under the skin. Further provided are methods of reducing body fat in a subject comprising topically administering the composition to the subject.
Patent AU-2019255307-A1 (AU)
Title: Systems and methods for securely managing data in distributed systems
Inventor: ARAYA ESTABAN
IPC: H04L9/08
Filed: 2019-04-17
Abstract: A cloud-based platform encrypts data imported from an organization using respective data encryption keys (DEK). The platform prevents decrypted data of the organization, and the DEK(s) used to encrypt such data, from being persistently retained within the platform. Access to the DEK may be controlled by the organization. Accordingly, the organization may retain control over access to its data, after the data has been exported to the platform. The platform may provide a purge control by which the organization can configure the platform the purge any cached DEK and/or unencrypted data pertaining to the organization.
Patent AU-2019261454-A1 (AU)
Title: Estrogen prodrugs and methods of administering estrogen prodrugs
Inventor: NICKISCH KLAUS
IPC: A61K9/00
Filed: 2019-04-25
Abstract: Disclosed herein is an intravaginal drug delivery device that includes one or more compartments, each of the one or more compartments comprising an estrogen prodrug and/or a progestin dispersed in a thermoplastic polymeric matrix.
Patent AU-2019262978-A1 (AU)
Title: C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
Inventor: PITZEN JENNIFER
IPC: C07D519/00
Filed: 2019-04-29
Abstract: The present disclosure relates to mTOR inhibitors. Specifically, the embodiments are directed to compounds and compositions inhibiting mTOR, methods of treating diseases mediated by mTOR, and methods of synthesizing these compounds.
Patent AU-2019272065-A1 (AU)
Title: Deep learning-based framework for identifying sequence patterns that cause sequence-specific errors (SSEs)
Inventor: KASHEFHAGHIGHI DORNA
IPC: G06N3/08
Filed: 2019-07-09
Abstract: The technology disclosed presents a deep learning-based framework, which identifies sequence patterns that cause sequence-specific errors (SSEs). Systems and methods train a variant filter on large-scale variant data to learn causal dependencies between sequence patterns and false variant calls. The variant filter has a hierarchical structure built on deep neural networks such as convolutional neural networks and fully-connected neural networks. Systems and methods implement a simulation that uses the variant filter to test known sequence patterns for their effect on variant filtering. The premise of the simulation is as follows: when a pair of a repeat pattern under test and a called variant is fed to the variant filter as part of a simulated input sequence and the variant filter classifies the called variant as a false variant call, then the repeat pattern is considered to have caused the false variant call and identified as SSE-causing.
Patent AU-2019285417-A1 (AU)
Title: Wheelchair, in particular manual wheelchair for bariatric or heavy-duty use
Inventor: RONCIN JEAN-MICHEL
IPC: A61G5/10
Filed: 2019-06-04
Abstract: There is described a wheelchair (1), in particular a manual wheelchair for bariatric or heavy-duty use, comprising a wheelchair chassis (30), a seating area (10), a backrest (20), as well as front wheels (45) and rear wheels (40), said backrest (20) comprising a backrest frame (21) supported onto the wheelchair chassis (30). According to the invention, the wheelchair (1) further comprises a rolling support structure (60) forming an integral part of the wheelchair (1; 1*), which rolling support structure (60; 60*) is mounted on a rear portion of the wheelchair (1) to support the wheelchair (1) in an upright position in which the wheelchair (1) is tilted back and is supported by the rolling support structure (60) to allow displacement of the wheelchair (1) in the upright position. The rolling support structure (60) includes at least three, in particular four, rolling elements (61, 62) providing rolling support for the wheelchair (1) in the upright position. The rolling elements (61, 62) preferably provide omnidirectional rolling support for the wheelchair (1) in the upright position, and may in particular be ball casters
Patent AU-2019289967-A1 (AU)
Title: OGA inhibitor compounds
Inventor: BARTOLOMÉ-NEBREDA JOSÉ MANUEL
IPC: A61K31/536
Filed: 2019-06-20
Abstract: The present invention relates to O-GlcNAc hydrolase (OGA) inhibitors. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which inhibition of OGA is beneficial, such as tauopathies, in particular Alzheimer's disease or progressive supranuclear palsy; and neurodegenerative diseases accompanied by a tau pathology, in particular amyotrophic lateral sclerosis or frontotemporal lobe dementia caused by C90RF72 mutations.
Patent AU-2019290399-A1 (AU)
Title: Systems, devices, and methods for amplifying signals of a lateral flow assay
Inventor: REN HUIMIAO
IPC: G01N33/531
Filed: 2019-06-06
Abstract: Lateral flow assay devices, systems, and methods described herein detect analyte present in a sample in low quantity or at low concentration by amplifying a signal generated at a detection zone. The generated signal can exceed a detection threshold of a measurement system and increase the sensitivity of the lateral flow assay devices, systems, and methods. In one aspect, the lateral flow device includes a signal-amplification conjugate that binds to a complex bound to immobilized capture agent in the detection zone, causing a chain reaction of binding events in the detection zone that result in an amplification of the signal generated in the detection zone.
Patent AU-2019296513-A1 (AU)
Title: Plant nutrient compositions
Inventor: SELBY-PHAM JAMIE
IPC: C05D7/00
Filed: 2019-06-14
Abstract: The present disclosure generally relates to solution dispersible plant nutrient compositions, and methods of preparing and use thereof. The solution dispersible plant nutrient composition can provide a plant nutrient with a source of nitrogen, phosphorus and potassium and where the composition comprises an amount of polyethylene glycol for facilitating dispersion and dissolution of the plant nutrient source into an aqueous solution.
Patent AU-2019302752-A1 (AU)
Title: Container assembly and system and method thereof
Inventor: MEFFORD DAVID
IPC: B65D23/08
Filed: 2019-07-11
Abstract: A container assembly comprised of a sleeve can be provided so as to circumscribe an underlying container and fixedly coupled to the underlying container at one or more portions of the underlying container. The container can have sidewalls with a surface geometry or geometries that prevent or make difficult the application of either a pre-printed pressure sensitive label or direct printing. Thus, the sleeve can have a decoration of label provided therein, while as the same time optionally allowing viewing access to the underlying container. The sleeve can be supported by the underlying container and may have a rigidity less than a rigidity of the sidewall(s) with the surface geometry of the underlying container.